Clinical Trials Logo

Weight Loss clinical trials

View clinical trials related to Weight Loss.

Filter by:

NCT ID: NCT05775172 Completed - Obesity Clinical Trials

Weight Loss Via Bariatric Surgery and Lifestyle Modification

Start date: June 1, 2021
Phase:
Study type: Observational [Patient Registry]

Gastric myoelectric, inflammatory, and hormonal responses, body compositional, energy expenditure, and metabolic changes during the development of obesity and the weight loss process are underinvestigated. This project studied the myoelectrical inflammatory and hormonal responses of the stomach, in addition to energy expenditure and body composition changes during weight loss via bariatric surgery and lifestyle intervention.

NCT ID: NCT05758363 Completed - Overweight Clinical Trials

Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals

Start date: March 9, 2023
Phase: N/A
Study type: Interventional

The aim of this randomized, parallel, two-arm, placebo-controlled, double-blind, multicenter clinical trial is to evaluate the efficacy of a dietary supplement on weight loss and psychological well-being in overweight individuals.

NCT ID: NCT05740670 Completed - Weight Loss Clinical Trials

The Safety and Efficacy of a Bone Broth Diet on Weight Loss in Obese Adults

Start date: January 25, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to investigate the safety and efficacy of a bone broth diet on weight loss in obese adults. The change in weight and body mass index (BMI) following the bone broth diet will be measured from baseline at Days 22 and 50. Additionally, the safety and tolerability of the bone broth diet will be measured by the occurrence of post-emergent adverse events (AEs).

NCT ID: NCT05715242 Completed - Obesity Clinical Trials

Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention

Start date: December 5, 2023
Phase: N/A
Study type: Interventional

The goal of this pilot trial is to learn about the optimal intensity level of goals in a digital weight loss intervention among adults with overweight or obesity. The main questions of the study are to assess the feasibility and acceptability of different goal intensities across four domains (calorie goal, step goal, eating window goal, red zone food goal). The investigators will recruit 32 total participants to the trial. Recruitment will occur through remote channels. Interested individuals will be directed to an online screening questionnaire; those who are eligible will then be invited to attend an initial remote session with study personnel to ensure interest and eligibility in the study. The weight loss intervention will last 10 weeks, and all participants will receive a "core" treatment consisting of self-monitoring weight, food intake, and steps (all via digital tools provided by the study team), along with behavioral lessons, action plans, and tailored feedback. Depending on which group participants are assigned to in the study, individuals will receive either a more or less challenging goal across the four domains. All study tasks will occur remotely, thus, participants will never come in-person for any tasks. Assessment of body weight and other measures will occur at the beginning of the trial ("baseline"), and at 4 weeks and 10 weeks. The investigators will use the Multiphase Optimization Strategy (MOST) framework to identify which of the goal intensity levels result in meaningful engagement and weight loss. The current study is the first step towards answering this question; it is designed as a pilot factorial trial, which focuses on feasibility and acceptability. In total, there will be 16 treatment conditions.

NCT ID: NCT05713058 Completed - Obesity Clinical Trials

Metabolic Effects of Early Time-restricted Carbohydrate Consumption

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

In this clinical trial, the investigators aim to examine the impact of a 12-week early time-restricted carbohydrate consumption diet on weight loss and glucose metabolism in patients with overweight/obesity and type 2 diabetes

NCT ID: NCT05711784 Completed - Clinical trials for Body Weight in the Overweight and Obese Class - I Population

A Clinical Safety and Efficacy Study in Subjects With Overweight or Obese Class - I, to Evaluate the Degree of Significant Weight Loss by Regular Intake of Phaseolean (White Kidney Bean Standardized Extract)

Start date: February 22, 2023
Phase: N/A
Study type: Interventional

A randomized, double-blinded, placebo-controlled, single-centre, clinical safety and efficacy study in subjects with overweight or Obese Class - I, to evaluate the degree of significant weight loss by regular intake of Phaseolean (White Kidney Bean Standardized Extract). This study is dose-response study to evaluate effectiveness of two different dosage i.e. 1500 mg Versus 3000 mg. 22 subjects will be enrolled per test treatment to complete 20 subjects per test treatment.

NCT ID: NCT05707845 Completed - Clinical trials for Premenstrual Syndrome

Effect of Weight Reduction and Aerobic Exercise on PMS Symptoms in Obese Females

PMS
Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study will be investigation of the effect of weight reduction and aerobic exercises on premenstrual syndrome symptoms in obese females.

NCT ID: NCT05702840 Completed - Clinical trials for Overweight and Obesity

EXerCise wEight Loss

EXCEL
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The overall aim of this study is to investigate the effects of home-based resistance exercise programme on changes in body composition and strength during weight loss, in people living with obesity or overweight.

NCT ID: NCT05635539 Completed - Clinical Trial Clinical Trials

Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The goal of this study was to evaluate the effects of the fast weight loss on clinic and laboratory inflammation profile, metabolic profile, reactive oxygen species (ROS) and body composition in patients with COVID and Influenza in comorbidity with NCDs. Primary endpoints: Clinic/infectious/inflammation tests for COVID and Influenza; weight loss during 14 days. Secondary endpoints: fasting blood glucose, HbA1c, blood insulin; systolic/diastolic BP; blood lipids; ALT, AST, chest CT-scan.

NCT ID: NCT05635097 Completed - Weight Loss Clinical Trials

Remote Weight Management Program for Obese Women

Start date: January 17, 2023
Phase: N/A
Study type: Interventional

The purpose of the research project is to see if counseling on the Mediterranean diet combined with motivational interviewing via a telemedicine platform (Zoom) while using smart technology ("smart" scales and tape) improves participants' weight loss, reduces waist circumference, and improves satisfaction with their care.